Detalhe da pesquisa
1.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
Nat Immunol
; 21(11): 1336-1345, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887977
2.
A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.
Angiogenesis
; 18(2): 209-17, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557927
3.
Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.
J Biol Chem
; 287(44): 36990-8, 2012 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22977237
4.
ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex.
Biomedicines
; 9(2)2021 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33572801
5.
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva.
JCI Insight
; 6(8)2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33705358
6.
Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.
bioRxiv
; 2020 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577665
7.
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells.
JBMR Plus
; 3(11): e10230, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768489
8.
A new class of small molecule inhibitor of BMP signaling.
PLoS One
; 8(4): e62721, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23646137